Corona Remedies IPO Today: Everything Investors Need to Know Before Applying
Corona Remedies IPO opens for subscription on Dec 8, 2025. Check price band, GMP, lot size, allotment date, and listing details for investors.
Corona Remedies IPO Today: Everything Investors Need to Know Before Applying
8th December 2025: The subscription process for the initial public offering (IPO) of Corona Remedies Ltd has been initiated. The pharmaceutical company, which is engaged in the developing, producing, and selling of products in the women healthcare, cardiology, pain management, urology, and other therapeutic areas, has received considerable investor interest on its first day.
Corona Remedies IPO Key Highlights
- IPO Opening: December 8, 2025
- IPO Closing: December 10, 2025
- Allotment Date: Possibly December 11, 2025
- Listing Date: December 15, 2025
- Markets: BSE and NSE
- Price Range: ₹1,008 - ₹1,062 per share
- Total Size: ₹655.37 crores (completely through an Offer for Sale of 61.71 lakh shares)
- Minimum Investment: ₹14,868 for retail investors
- Book Running Lead Manager: JM Financial Ltd.
- Registrar: Bigshare Services Pvt. Ltd.
High Grey Market Premium (GMP) Signifies Strong Demand
The shares of Corona Remedies are ruling with a strong grey market premium (GMP) in the unlisting market.
- Today's GMP: ₹290 per share
- Grey Market Price: ₹1,352 per share
- Premium over IPO Price: 27.31% over the issue price of ₹1,062
This remarkable GMP signifies investor trust in the firm and expectation of a successful listing.
Reasons for Investors’ Interest in Corona Remedies IPO
Corona Remedies has a wide-ranging pharmaceutical product portfolio covering essential therapeutic areas making it a draw for both retail and institutional investors. The IPO offers an opportunity to invest in a rapidly expanding healthcare business with a vast growth potential.
Aside from the first day already alive, the buzz is loud in the market and the investors are watching the trends in the subscriptions, the movements in the GMP, and the sector interest to judge the IPO's possible performance when it gets listed.
Things to Look Out For
- Allotment Status: Probably on December 11
- Price & Gains at Listing: Predicted for December 15
- Investor Sentiment: Strong retail and institutional demand as indicated by GMP
- Sector Trends: The pharmaceutical sector is still attractive due to the healthcare growth
14 shares are the lot size and minimum investment of ₹14,868 is the amount that investors who want to participate should consider.
The IPO of Corona Remedies is creating as one of the most awaited pharma listings of 2025, which is a sign of strong market confidence and healthy demand in both primary and grey-market channels.
